ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nicergoline Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-9I7713
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Nicergoline Market Insights Forecast to 2028
BUY CHAPTERS

Global Nicergoline Market Research Report 2025

Code: QYRE-Auto-9I7713
Report
July 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Teva API
Fareva
Olon Group
Hainan Poly Pharm Co., Ltd
DEAFARMA
Fengchen
LGC
Selleck Chemicals
Tocris Bioscience
Solarium Pharmaceuticals
Pfizer Pharmaceutical Co., Ltd.
Hebei Lingding Biotechnology Co., Ltd.
Shandong FANGMING Pharmaceutical Group Co., Ltd.
Hainan General & Kangli Pharmaceutical Co., Ltd.
Hainan Zambon Pharmaceutical Co., Ltd.
Pharmacia
Shandong Qidu Pharmaceutical Co., Ltd.
Kunshan Rotam Reddy Pharmaceutical Co. Ltd.
Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.

Nicergoline Market Size

The global market for Nicergoline was valued at US$ 1077 million in the year 2024 and is projected to reach a revised size of US$ 3111 million by 2031, growing at a CAGR of 16.6% during the forecast period.

Nicergoline Market

Nicergoline Market

Nicergoline is an ergot derivative indicated to treat senile dementia and vascular disorders such as cerebral thrombosis, Raynaud"s disease, vascular migraines, atherosclerosis, arterial blockages in the limbs, and retinopathy. It is also indicated for migraines of vascular origin, coadjutant therapy in clinical situations, corio-retinal vascular disorders, oto-vestibular problems. It is sold under the brand name Sermion among others. Nicergoline is a potent vasodilator that helps improve brain blood flow by decreases vascular resistance and improving the utilization of glucose and oxygen by brain cells.
The global nicergoline market is projected to grow steadily. The rising burden of vascular disorders worldwide will drive the demand for Nicergoline. Rising incidences of complications due to vascular disorders are anticipated to drive the demand for Nicergoline. Increasing prevalence of cerebral thrombosis, Raynaud"s disease, vascular migraines, atherosclerosis, arterial blockages in the limbs, and retinopathy are projected to raise volume calls for Nicergoline. Growing FDA approval for new disease treatments is foreseen to create new growth opportunities. However, the availability of other substitutes in the market is likely to restrain the market growth. Specific challenges are roaming around the market. Adverse events have been noted associated with allergic or hypersensitivity-type reactions after the Nicergoline injection into the body. This may hinder the market growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nicergoline, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicergoline.
The Nicergoline market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nicergoline market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nicergoline manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nicergoline Market Report

Report Metric Details
Report Name Nicergoline Market
Accounted market size in year US$ 1077 million
Forecasted market size in 2031 US$ 3111 million
CAGR 16.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • For Injection
  • For Oral
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Teva API, FAREVA, Olon Group, Hainan Poly Pharm Co. Ltd, DEAFARMA, Solarium Pharmaceuticals, Fengchen, LGC, Pfizer Pharmaceutical Co., Ltd., Hebei Lingding Biotechnology Co., Ltd., Selleck Chemicals, Tocris Bioscience, Kunshan Rotam Reddy Pharmaceutical Co. Ltd., Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd., Shandong Fangming Pharmaceutical Group Co. Ltd., Hainan General Kangli Pharmaceutical Co. Ltd., Hainan Zambon Pharmaceutical Co. Ltd, Pharmacia, Shandong Qidu Pharmaceutical Co. Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nicergoline manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nicergoline in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Nicergoline Market growing?

Ans: The Nicergoline Market witnessing a CAGR of 16.6% during the forecast period 2025-2031.

What is the Nicergoline Market size in 2031?

Ans: The Nicergoline Market size in 2031 will be US$ 3111 million.

Who are the main players in the Nicergoline Market report?

Ans: The main players in the Nicergoline Market are Teva API, FAREVA, Olon Group, Hainan Poly Pharm Co. Ltd, DEAFARMA, Solarium Pharmaceuticals, Fengchen, LGC, Pfizer Pharmaceutical Co., Ltd., Hebei Lingding Biotechnology Co., Ltd., Selleck Chemicals, Tocris Bioscience, Kunshan Rotam Reddy Pharmaceutical Co. Ltd., Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd., Shandong Fangming Pharmaceutical Group Co. Ltd., Hainan General Kangli Pharmaceutical Co. Ltd., Hainan Zambon Pharmaceutical Co. Ltd, Pharmacia, Shandong Qidu Pharmaceutical Co. Ltd.

What are the Application segmentation covered in the Nicergoline Market report?

Ans: The Applications covered in the Nicergoline Market report are Alzheimer's Disease (AD), Arterial Hypertension, Cerebral Thrombosis, Others

What are the Type segmentation covered in the Nicergoline Market report?

Ans: The Types covered in the Nicergoline Market report are For Injection, For Oral

Recommended Reports

Cardiovascular Disorders

CNS & Brain Health

Vascular & Thrombotic Therapy

1 Nicergoline Market Overview
1.1 Product Definition
1.2 Nicergoline by Type
1.2.1 Global Nicergoline Market Value Comparison by Type (2024 VS 2031)
1.2.2 For Injection
1.2.3 For Oral
1.3 Nicergoline by Application
1.3.1 Global Nicergoline Market Value by Application (2024 VS 2031)
1.3.2 Alzheimer's Disease (AD)
1.3.3 Arterial Hypertension
1.3.4 Cerebral Thrombosis
1.3.5 Others
1.4 Global Nicergoline Market Size Estimates and Forecasts
1.4.1 Global Nicergoline Revenue 2020-2031
1.4.2 Global Nicergoline Sales 2020-2031
1.4.3 Global Nicergoline Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nicergoline Market Competition by Manufacturers
2.1 Global Nicergoline Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nicergoline Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nicergoline Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nicergoline, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nicergoline, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nicergoline, Product Type & Application
2.7 Global Key Manufacturers of Nicergoline, Date of Enter into This Industry
2.8 Global Nicergoline Market Competitive Situation and Trends
2.8.1 Global Nicergoline Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nicergoline Players Market Share by Revenue
2.8.3 Global Nicergoline Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nicergoline Market Scenario by Region
3.1 Global Nicergoline Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nicergoline Sales by Region: 2020-2031
3.2.1 Global Nicergoline Sales by Region: 2020-2025
3.2.2 Global Nicergoline Sales by Region: 2026-2031
3.3 Global Nicergoline Revenue by Region: 2020-2031
3.3.1 Global Nicergoline Revenue by Region: 2020-2025
3.3.2 Global Nicergoline Revenue by Region: 2026-2031
3.4 North America Nicergoline Market Facts & Figures by Country
3.4.1 North America Nicergoline Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nicergoline Sales by Country (2020-2031)
3.4.3 North America Nicergoline Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nicergoline Market Facts & Figures by Country
3.5.1 Europe Nicergoline Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nicergoline Sales by Country (2020-2031)
3.5.3 Europe Nicergoline Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nicergoline Market Facts & Figures by Region
3.6.1 Asia Pacific Nicergoline Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nicergoline Sales by Region (2020-2031)
3.6.3 Asia Pacific Nicergoline Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Nicergoline Market Facts & Figures by Country
3.7.1 Latin America Nicergoline Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nicergoline Sales by Country (2020-2031)
3.7.3 Latin America Nicergoline Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nicergoline Market Facts & Figures by Country
3.8.1 Middle East and Africa Nicergoline Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nicergoline Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nicergoline Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nicergoline Sales by Type (2020-2031)
4.1.1 Global Nicergoline Sales by Type (2020-2025)
4.1.2 Global Nicergoline Sales by Type (2026-2031)
4.1.3 Global Nicergoline Sales Market Share by Type (2020-2031)
4.2 Global Nicergoline Revenue by Type (2020-2031)
4.2.1 Global Nicergoline Revenue by Type (2020-2025)
4.2.2 Global Nicergoline Revenue by Type (2026-2031)
4.2.3 Global Nicergoline Revenue Market Share by Type (2020-2031)
4.3 Global Nicergoline Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nicergoline Sales by Application (2020-2031)
5.1.1 Global Nicergoline Sales by Application (2020-2025)
5.1.2 Global Nicergoline Sales by Application (2026-2031)
5.1.3 Global Nicergoline Sales Market Share by Application (2020-2031)
5.2 Global Nicergoline Revenue by Application (2020-2031)
5.2.1 Global Nicergoline Revenue by Application (2020-2025)
5.2.2 Global Nicergoline Revenue by Application (2026-2031)
5.2.3 Global Nicergoline Revenue Market Share by Application (2020-2031)
5.3 Global Nicergoline Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Teva API
6.1.1 Teva API Company Information
6.1.2 Teva API Description and Business Overview
6.1.3 Teva API Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Teva API Nicergoline Product Portfolio
6.1.5 Teva API Recent Developments/Updates
6.2 FAREVA
6.2.1 FAREVA Company Information
6.2.2 FAREVA Description and Business Overview
6.2.3 FAREVA Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.2.4 FAREVA Nicergoline Product Portfolio
6.2.5 FAREVA Recent Developments/Updates
6.3 Olon Group
6.3.1 Olon Group Company Information
6.3.2 Olon Group Description and Business Overview
6.3.3 Olon Group Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Olon Group Nicergoline Product Portfolio
6.3.5 Olon Group Recent Developments/Updates
6.4 Hainan Poly Pharm Co. Ltd
6.4.1 Hainan Poly Pharm Co. Ltd Company Information
6.4.2 Hainan Poly Pharm Co. Ltd Description and Business Overview
6.4.3 Hainan Poly Pharm Co. Ltd Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hainan Poly Pharm Co. Ltd Nicergoline Product Portfolio
6.4.5 Hainan Poly Pharm Co. Ltd Recent Developments/Updates
6.5 DEAFARMA
6.5.1 DEAFARMA Company Information
6.5.2 DEAFARMA Description and Business Overview
6.5.3 DEAFARMA Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.5.4 DEAFARMA Nicergoline Product Portfolio
6.5.5 DEAFARMA Recent Developments/Updates
6.6 Solarium Pharmaceuticals
6.6.1 Solarium Pharmaceuticals Company Information
6.6.2 Solarium Pharmaceuticals Description and Business Overview
6.6.3 Solarium Pharmaceuticals Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Solarium Pharmaceuticals Nicergoline Product Portfolio
6.6.5 Solarium Pharmaceuticals Recent Developments/Updates
6.7 Fengchen
6.7.1 Fengchen Company Information
6.7.2 Fengchen Description and Business Overview
6.7.3 Fengchen Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Fengchen Nicergoline Product Portfolio
6.7.5 Fengchen Recent Developments/Updates
6.8 LGC
6.8.1 LGC Company Information
6.8.2 LGC Description and Business Overview
6.8.3 LGC Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.8.4 LGC Nicergoline Product Portfolio
6.8.5 LGC Recent Developments/Updates
6.9 Pfizer Pharmaceutical Co., Ltd.
6.9.1 Pfizer Pharmaceutical Co., Ltd. Company Information
6.9.2 Pfizer Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Pfizer Pharmaceutical Co., Ltd. Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pfizer Pharmaceutical Co., Ltd. Nicergoline Product Portfolio
6.9.5 Pfizer Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Hebei Lingding Biotechnology Co., Ltd.
6.10.1 Hebei Lingding Biotechnology Co., Ltd. Company Information
6.10.2 Hebei Lingding Biotechnology Co., Ltd. Description and Business Overview
6.10.3 Hebei Lingding Biotechnology Co., Ltd. Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hebei Lingding Biotechnology Co., Ltd. Nicergoline Product Portfolio
6.10.5 Hebei Lingding Biotechnology Co., Ltd. Recent Developments/Updates
6.11 Selleck Chemicals
6.11.1 Selleck Chemicals Company Information
6.11.2 Selleck Chemicals Description and Business Overview
6.11.3 Selleck Chemicals Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Selleck Chemicals Nicergoline Product Portfolio
6.11.5 Selleck Chemicals Recent Developments/Updates
6.12 Tocris Bioscience
6.12.1 Tocris Bioscience Company Information
6.12.2 Tocris Bioscience Description and Business Overview
6.12.3 Tocris Bioscience Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Tocris Bioscience Nicergoline Product Portfolio
6.12.5 Tocris Bioscience Recent Developments/Updates
6.13 Kunshan Rotam Reddy Pharmaceutical Co. Ltd.
6.13.1 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Company Information
6.13.2 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Description and Business Overview
6.13.3 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
6.13.5 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Recent Developments/Updates
6.14 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.
6.14.1 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Company Information
6.14.2 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Description and Business Overview
6.14.3 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
6.14.5 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Recent Developments/Updates
6.15 Shandong Fangming Pharmaceutical Group Co. Ltd.
6.15.1 Shandong Fangming Pharmaceutical Group Co. Ltd. Company Information
6.15.2 Shandong Fangming Pharmaceutical Group Co. Ltd. Description and Business Overview
6.15.3 Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Product Portfolio
6.15.5 Shandong Fangming Pharmaceutical Group Co. Ltd. Recent Developments/Updates
6.16 Hainan General Kangli Pharmaceutical Co. Ltd.
6.16.1 Hainan General Kangli Pharmaceutical Co. Ltd. Company Information
6.16.2 Hainan General Kangli Pharmaceutical Co. Ltd. Description and Business Overview
6.16.3 Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
6.16.5 Hainan General Kangli Pharmaceutical Co. Ltd. Recent Developments/Updates
6.17 Hainan Zambon Pharmaceutical Co. Ltd
6.17.1 Hainan Zambon Pharmaceutical Co. Ltd Company Information
6.17.2 Hainan Zambon Pharmaceutical Co. Ltd Description and Business Overview
6.17.3 Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Product Portfolio
6.17.5 Hainan Zambon Pharmaceutical Co. Ltd Recent Developments/Updates
6.18 Pharmacia
6.18.1 Pharmacia Company Information
6.18.2 Pharmacia Description and Business Overview
6.18.3 Pharmacia Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Pharmacia Nicergoline Product Portfolio
6.18.5 Pharmacia Recent Developments/Updates
6.19 Shandong Qidu Pharmaceutical Co. Ltd.
6.19.1 Shandong Qidu Pharmaceutical Co. Ltd. Company Information
6.19.2 Shandong Qidu Pharmaceutical Co. Ltd. Description and Business Overview
6.19.3 Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
6.19.5 Shandong Qidu Pharmaceutical Co. Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nicergoline Industry Chain Analysis
7.2 Nicergoline Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nicergoline Production Mode & Process Analysis
7.4 Nicergoline Sales and Marketing
7.4.1 Nicergoline Sales Channels
7.4.2 Nicergoline Distributors
7.5 Nicergoline Customer Analysis
8 Nicergoline Market Dynamics
8.1 Nicergoline Industry Trends
8.2 Nicergoline Market Drivers
8.3 Nicergoline Market Challenges
8.4 Nicergoline Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Teva API
Fareva
Olon Group
Hainan Poly Pharm Co., Ltd
DEAFARMA
Fengchen
LGC
Selleck Chemicals
Tocris Bioscience
Solarium Pharmaceuticals
Pfizer Pharmaceutical Co., Ltd.
Hebei Lingding Biotechnology Co., Ltd.
Shandong FANGMING Pharmaceutical Group Co., Ltd.
Hainan General & Kangli Pharmaceutical Co., Ltd.
Hainan Zambon Pharmaceutical Co., Ltd.
Pharmacia
Shandong Qidu Pharmaceutical Co., Ltd.
Kunshan Rotam Reddy Pharmaceutical Co. Ltd.
Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.
List of Tables
 Table 1. Global Nicergoline Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nicergoline Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nicergoline Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nicergoline Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Nicergoline Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nicergoline Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nicergoline Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nicergoline Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nicergoline, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nicergoline, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nicergoline, Product Type & Application
 Table 12. Global Key Manufacturers of Nicergoline, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nicergoline by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicergoline as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nicergoline Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nicergoline Sales by Region (2020-2025) & (K Units)
 Table 18. Global Nicergoline Sales Market Share by Region (2020-2025)
 Table 19. Global Nicergoline Sales by Region (2026-2031) & (K Units)
 Table 20. Global Nicergoline Sales Market Share by Region (2026-2031)
 Table 21. Global Nicergoline Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nicergoline Revenue Market Share by Region (2020-2025)
 Table 23. Global Nicergoline Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nicergoline Revenue Market Share by Region (2026-2031)
 Table 25. North America Nicergoline Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nicergoline Sales by Country (2020-2025) & (K Units)
 Table 27. North America Nicergoline Sales by Country (2026-2031) & (K Units)
 Table 28. North America Nicergoline Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nicergoline Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nicergoline Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nicergoline Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Nicergoline Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Nicergoline Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nicergoline Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nicergoline Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nicergoline Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Nicergoline Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Nicergoline Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nicergoline Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nicergoline Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nicergoline Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Nicergoline Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Nicergoline Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nicergoline Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nicergoline Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nicergoline Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Nicergoline Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Nicergoline Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nicergoline Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nicergoline Sales (K Units) by Type (2020-2025)
 Table 51. Global Nicergoline Sales (K Units) by Type (2026-2031)
 Table 52. Global Nicergoline Sales Market Share by Type (2020-2025)
 Table 53. Global Nicergoline Sales Market Share by Type (2026-2031)
 Table 54. Global Nicergoline Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nicergoline Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nicergoline Revenue Market Share by Type (2020-2025)
 Table 57. Global Nicergoline Revenue Market Share by Type (2026-2031)
 Table 58. Global Nicergoline Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Nicergoline Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Nicergoline Sales (K Units) by Application (2020-2025)
 Table 61. Global Nicergoline Sales (K Units) by Application (2026-2031)
 Table 62. Global Nicergoline Sales Market Share by Application (2020-2025)
 Table 63. Global Nicergoline Sales Market Share by Application (2026-2031)
 Table 64. Global Nicergoline Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nicergoline Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nicergoline Revenue Market Share by Application (2020-2025)
 Table 67. Global Nicergoline Revenue Market Share by Application (2026-2031)
 Table 68. Global Nicergoline Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Nicergoline Price (USD/Unit) by Application (2026-2031)
 Table 70. Teva API Company Information
 Table 71. Teva API Description and Business Overview
 Table 72. Teva API Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Teva API Nicergoline Product
 Table 74. Teva API Recent Developments/Updates
 Table 75. FAREVA Company Information
 Table 76. FAREVA Description and Business Overview
 Table 77. FAREVA Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. FAREVA Nicergoline Product
 Table 79. FAREVA Recent Developments/Updates
 Table 80. Olon Group Company Information
 Table 81. Olon Group Description and Business Overview
 Table 82. Olon Group Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Olon Group Nicergoline Product
 Table 84. Olon Group Recent Developments/Updates
 Table 85. Hainan Poly Pharm Co. Ltd Company Information
 Table 86. Hainan Poly Pharm Co. Ltd Description and Business Overview
 Table 87. Hainan Poly Pharm Co. Ltd Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Hainan Poly Pharm Co. Ltd Nicergoline Product
 Table 89. Hainan Poly Pharm Co. Ltd Recent Developments/Updates
 Table 90. DEAFARMA Company Information
 Table 91. DEAFARMA Description and Business Overview
 Table 92. DEAFARMA Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. DEAFARMA Nicergoline Product
 Table 94. DEAFARMA Recent Developments/Updates
 Table 95. Solarium Pharmaceuticals Company Information
 Table 96. Solarium Pharmaceuticals Description and Business Overview
 Table 97. Solarium Pharmaceuticals Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Solarium Pharmaceuticals Nicergoline Product
 Table 99. Solarium Pharmaceuticals Recent Developments/Updates
 Table 100. Fengchen Company Information
 Table 101. Fengchen Description and Business Overview
 Table 102. Fengchen Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Fengchen Nicergoline Product
 Table 104. Fengchen Recent Developments/Updates
 Table 105. LGC Company Information
 Table 106. LGC Description and Business Overview
 Table 107. LGC Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. LGC Nicergoline Product
 Table 109. LGC Recent Developments/Updates
 Table 110. Pfizer Pharmaceutical Co., Ltd. Company Information
 Table 111. Pfizer Pharmaceutical Co., Ltd. Description and Business Overview
 Table 112. Pfizer Pharmaceutical Co., Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Pfizer Pharmaceutical Co., Ltd. Nicergoline Product
 Table 114. Pfizer Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 115. Hebei Lingding Biotechnology Co., Ltd. Company Information
 Table 116. Hebei Lingding Biotechnology Co., Ltd. Description and Business Overview
 Table 117. Hebei Lingding Biotechnology Co., Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Hebei Lingding Biotechnology Co., Ltd. Nicergoline Product
 Table 119. Hebei Lingding Biotechnology Co., Ltd. Recent Developments/Updates
 Table 120. Selleck Chemicals Company Information
 Table 121. Selleck Chemicals Description and Business Overview
 Table 122. Selleck Chemicals Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Selleck Chemicals Nicergoline Product
 Table 124. Selleck Chemicals Recent Developments/Updates
 Table 125. Tocris Bioscience Company Information
 Table 126. Tocris Bioscience Description and Business Overview
 Table 127. Tocris Bioscience Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Tocris Bioscience Nicergoline Product
 Table 129. Tocris Bioscience Recent Developments/Updates
 Table 130. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Company Information
 Table 131. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Description and Business Overview
 Table 132. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Product
 Table 134. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Recent Developments/Updates
 Table 135. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Company Information
 Table 136. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Description and Business Overview
 Table 137. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Product
 Table 139. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Recent Developments/Updates
 Table 140. Shandong Fangming Pharmaceutical Group Co. Ltd. Company Information
 Table 141. Shandong Fangming Pharmaceutical Group Co. Ltd. Description and Business Overview
 Table 142. Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Product
 Table 144. Shandong Fangming Pharmaceutical Group Co. Ltd. Recent Developments/Updates
 Table 145. Hainan General Kangli Pharmaceutical Co. Ltd. Company Information
 Table 146. Hainan General Kangli Pharmaceutical Co. Ltd. Description and Business Overview
 Table 147. Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Product
 Table 149. Hainan General Kangli Pharmaceutical Co. Ltd. Recent Developments/Updates
 Table 150. Hainan Zambon Pharmaceutical Co. Ltd Company Information
 Table 151. Hainan Zambon Pharmaceutical Co. Ltd Description and Business Overview
 Table 152. Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 153. Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Product
 Table 154. Hainan Zambon Pharmaceutical Co. Ltd Recent Developments/Updates
 Table 155. Pharmacia Company Information
 Table 156. Pharmacia Description and Business Overview
 Table 157. Pharmacia Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 158. Pharmacia Nicergoline Product
 Table 159. Pharmacia Recent Developments/Updates
 Table 160. Shandong Qidu Pharmaceutical Co. Ltd. Company Information
 Table 161. Shandong Qidu Pharmaceutical Co. Ltd. Description and Business Overview
 Table 162. Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 163. Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Product
 Table 164. Shandong Qidu Pharmaceutical Co. Ltd. Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Nicergoline Distributors List
 Table 168. Nicergoline Customers List
 Table 169. Nicergoline Market Trends
 Table 170. Nicergoline Market Drivers
 Table 171. Nicergoline Market Challenges
 Table 172. Nicergoline Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nicergoline
 Figure 2. Global Nicergoline Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nicergoline Market Share by Type: 2024 & 2031
 Figure 4. For Injection Product Picture
 Figure 5. For Oral Product Picture
 Figure 6. Global Nicergoline Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Nicergoline Market Share by Application: 2024 & 2031
 Figure 8. Alzheimer's Disease (AD)
 Figure 9. Arterial Hypertension
 Figure 10. Cerebral Thrombosis
 Figure 11. Others
 Figure 12. Global Nicergoline Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Nicergoline Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Nicergoline Sales (2020-2031) & (K Units)
 Figure 15. Global Nicergoline Average Price (USD/Unit) & (2020-2031)
 Figure 16. Nicergoline Report Years Considered
 Figure 17. Nicergoline Sales Share by Manufacturers in 2024
 Figure 18. Global Nicergoline Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Nicergoline Players: Market Share by Revenue in Nicergoline in 2024
 Figure 20. Nicergoline Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Nicergoline Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Nicergoline Sales Market Share by Country (2020-2031)
 Figure 23. North America Nicergoline Revenue Market Share by Country (2020-2031)
 Figure 24. United States Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Nicergoline Sales Market Share by Country (2020-2031)
 Figure 27. Europe Nicergoline Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Nicergoline Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Nicergoline Revenue Market Share by Region (2020-2031)
 Figure 35. China Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Nicergoline Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Nicergoline Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Colombia Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Nicergoline Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Nicergoline Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Nicergoline Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Nicergoline by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Nicergoline by Type (2020-2031)
 Figure 57. Global Nicergoline Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Nicergoline by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Nicergoline by Application (2020-2031)
 Figure 60. Global Nicergoline Price (USD/Unit) by Application (2020-2031)
 Figure 61. Nicergoline Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Ergometrine Maleate Market Research Report 2025
Global Ergometrine Maleate API Market Research Report 2025
Global Bromocriptine Mesylate API Market Research Report 2024
Dementia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nicergoline API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Selegiline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cabergoline API Market Research Report 2025
Global Pharmaceutical Grade Ergothioneine Market Research Report 2025
Cabergoline Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nadolol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ganirelix Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cabergoline Market Insights Forecast to 2030
Global Sarpogrelate Hydrochloride Tablets Market Research Report 2024
Global Ganirelix API Market Research Report 2024
Global Rasagiline Mesylate Tablets Market Research Report 2024
Global Riociguat Market Research Report 2024
Dimenhydrinate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ganirelix Acetate API Market Research Report 2024
Global Naphazoline Hydrochloride Market Research Report 2024
Global Degarelix Market Insights Forecast to 2030

RELATED REPORTS

Global Nano Porous Silicon–carbon Anode Material Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0F17509
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Foam Board Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16F19834
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Copper Wires Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5U6954
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Quartz Fiber Cloth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20G17359
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions